The Aura Strategy Logo
The Aura Strategy Logo

What is FOXO4-DRI?

Research Focus: Longevity

Benefits, Research & Legality (2025 Guide)

FOXO4-DRI (D-Retro-Inverso) is a synthetic peptide designed to selectively induce apoptosis (programmed cell death) in senescent cells (zombie cells). It is a key compound in senolytic research.

At a Glance

Senescent cells accumulate with age and secrete inflammatory factors that damage surrounding healthy tissue. FOXO4-DRI works by disrupting the interaction between the FOXO4 protein and p53, a pathway that keeps senescent cells alive. This section provides a general overview of its research context.

About FOXO4-DRI

Senescent cells accumulate with age and secrete inflammatory factors that damage surrounding healthy tissue. FOXO4-DRI works by disrupting the interaction between the FOXO4 protein and p53, a pathway that keeps senescent cells alive.

How It Works

Senolytic Action

Selectively targets and eliminates senescent cells, reducing the burden of 'zombie cells' in tissues.

p53 Pathway Disruption

Interferes with the FOXO4-p53 interaction, triggering apoptosis in senescent cells.

Current Research Insights

Senescence Clearing

FOXO4-DRI is highly regarded in anti-aging research for its potential to clear out damaged cells, leading to tissue rejuvenation and improved function.

Areas of Study

Anti-Aging and Rejuvenation

Investigated for reversing age-related decline and improving organ function.

Age-Related Diseases

Studied for its potential role in conditions like kidney failure and hair loss linked to senescence.

Research Use Only Section

FOXO4-DRI is strictly intended for laboratory and clinical research:

  • Available exclusively from authorized research suppliers
  • Not FDA-approved for general therapeutic use
  • Comprehensive safety, efficacy, and dosage guidelines remain under ongoing investigation

FAQs

Research

  • Studies on senolytics and their mechanism of action, particularly the FOXO4-p53 pathway.
  • Research into the effects of senescent cell clearance on tissue health.

(The above references are representative and support the research context of this peptide, GLP hormone or regenerative therapy. All claims are for research purposes only and do not imply approved medical use.)